PTEN 2, a Golgi-associated testis-specific homologue or the PTEN tumor suppressor lipid phosphatase

被引:77
作者
Wu, Y
Dowbenko, D
Pisabarro, MT
Dillard-Telm, L
Koeppen, H
Lasky, LA
机构
[1] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA
[3] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA
关键词
D O I
10.1074/jbc.M101480200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor PTEN is a phosphatidylinositol phospholipid phosphatase, which indirectly down-regulates the activity of the protein kinase B/Akt survival kinases. Examination of sequence data bases revealed the existence of a highly conserved homologue of PTEN, This homologue, termed PTEN 2, contained an extended amino-terminal domain having four potential transmembrane motifs, a lipid phosphatase domain, and a potential lipid-binding C2 domain. Transcript analysis demonstrated that PTEN 2 is expressed only in testis and specifically in secondary spermatocytes, In contrast to PTEN, PTEN 2 was localized to the Golgi apparatus via the amino-terminal membrane-spanning regions. Molecular modeling suggested that PTEN 2 is a phospholipid phosphatase with potential specificity for the phosphate at the 3 position of inositol phosphates, Enzymatic analysis of PTEN 2 revealed substrate specificity that is similar to PTEN, with a preference for the dephosphorylation of the phosphatidylinositol 3,5-phosphate phospholipid, a known mediator of vesicular trafficking. Together, these data suggest that PTEN 2 is a Golgi-localized, testis-specific phospholipid phosphatase, which may contribute to the terminal stages of spermatocyte differentiation.
引用
收藏
页码:21745 / 21753
页数:9
相关论文
共 33 条
[21]   The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate [J].
Maehama, T ;
Dixon, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13375-13378
[22]   A sensitive assay for phosphoinositide phosphatases [J].
Maehama, T ;
Taylor, GS ;
Slama, JT ;
Dixon, JE .
ANALYTICAL BIOCHEMISTRY, 2000, 279 (02) :248-250
[23]   The C-elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway [J].
Ogg, S ;
Ruvkun, G .
MOLECULAR CELL, 1998, 2 (06) :887-893
[24]  
Rasheed BKA, 1997, CANCER RES, V57, P4187
[25]  
Reaves BJ, 1996, J CELL SCI, V109, P749
[26]   Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN [J].
Stambolic, V ;
Suzuki, A ;
de la Pompa, JL ;
Brothers, GM ;
Mirtsos, C ;
Sasaki, T ;
Ruland, J ;
Penninger, JM ;
Siderovski, DP ;
Mak, TW .
CELL, 1998, 95 (01) :29-39
[27]   Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers [J].
Steck, PA ;
Pershouse, MA ;
Jasser, SA ;
Yung, WKA ;
Lin, H ;
Ligon, AH ;
Langford, LA ;
Baumgard, ML ;
Hattier, T ;
Davis, T ;
Frye, C ;
Hu, R ;
Swedlund, B ;
Teng, DHF ;
Tavtigian, SV .
NATURE GENETICS, 1997, 15 (04) :356-362
[28]  
Tashiro H, 1997, CANCER RES, V57, P3935
[29]   Signalling through the lipid products of phosphoinositide-3-OH kinase [J].
Toker, A ;
Cantley, LC .
NATURE, 1997, 387 (6634) :673-676
[30]   Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction [J].
Watton, SJ ;
Downward, J .
CURRENT BIOLOGY, 1999, 9 (08) :433-436